Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Co Ltd. (BHVN) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biohaven Pharmaceutical Holding Co Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1689813.
Total stock buying since 2017: $29,797,328.
Total stock sales since 2017: $8,254,121,441.
Total stock option exercises since 2017: $40,164,886.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 38,000 | $5,625,672 | 13,575 | $1,692,028 | 70,732 | $365,280 |
| 2021 | 28,157 | $2,466,412 | 140,038 | $15,560,705 | 1,203,383 | $25,316,748 |
| 2020 | 40,000 | $2,567,469 | 1,498,612 | $91,940,805 | 869,614 | $9,385,646 |
| 2019 | 25,000 | $1,006,425 | 926,180 | $45,122,660 | 518,456 | $4,767,859 |
| 2018 | 0 | $0 | 1,244,815 | $8,086,647,381 | 42,500 | $25,925 |
| 2017 | 1,066,550 | $18,131,350 | 485,538 | $13,157,862 | 70,538 | $303,428 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-08 | 38,000 | $5,625,672 | 0 | $0 | 0 | $0 |
| 2022-05 | 0 | $0 | 4,200 | $594,300 | 2,250 | $120,960 |
| 2022-01 | 0 | $0 | 9,375 | $1,097,728 | 68,482 | $244,320 |
| 2021-12 | 0 | $0 | 77,773 | $8,384,799 | 88,358 | $739,659 |
| 2021-11 | 5,000 | $615,110 | 62,265 | $7,175,906 | 1,080,025 | $24,577,089 |
| 2021-03 | 23,157 | $1,851,302 | 0 | $0 | 0 | $0 |
| 2021-01 | 0 | $0 | 0 | $0 | 35,000 | $0 |
| 2020-11 | 5,000 | $447,735 | 30,000 | $2,307,210 | 59,025 | $1,521,600 |
| 2020-10 | 0 | $0 | 73,500 | $5,766,233 | 23,500 | $218,314 |
| 2020-09 | 10,000 | $590,809 | 0 | $0 | 0 | $0 |
| 2020-08 | 25,000 | $1,528,925 | 0 | $0 | 0 | $0 |
| 2020-07 | 0 | $0 | 108,404 | $8,172,043 | 58,404 | $35,626 |
| 2020-06 | 0 | $0 | 904,687 | $62,750,749 | 692,887 | $7,092,066 |
| 2020-04 | 0 | $0 | 350,000 | $11,137,750 | 0 | $0 |
| 2020-01 | 0 | $0 | 32,021 | $1,806,820 | 35,798 | $518,040 |
| 2019-12 | 0 | $0 | 132,609 | $7,208,145 | 162,259 | $234,440 |
| 2019-11 | 0 | $0 | 44,979 | $2,403,103 | 44,979 | $563,888 |
| 2019-10 | 0 | $0 | 18,500 | $833,764 | 18,500 | $200,170 |
| 2019-09 | 0 | $0 | 10,000 | $450,000 | 10,000 | $255,100 |
| 2019-08 | 5,000 | $188,250 | 0 | $0 | 0 | $0 |
| 2019-06 | 20,000 | $818,175 | 0 | $0 | 0 | $0 |
| 2019-04 | 0 | $0 | 88,825 | $5,189,444 | 0 | $0 |
| 2019-03 | 0 | $0 | 171,770 | $8,452,560 | 225,000 | $2,090,247 |
| 2019-02 | 0 | $0 | 448,997 | $20,190,109 | 47,218 | $1,326,470 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-19 | Bailey Gregory | Buy | 38,000 | 148.04 | 5,625,672 |
| 2022-05-10 | Clark George C. (VP, Chief Accounting Officer) | Sale | 4,200 | 141.50 | 594,300 |
| 2022-05-10 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 2,250 | 53.76 | 120,960 |
| 2022-01-19 | Clark George C. (VP, Chief Accounting Officer) | Sale | 9,375 | 117.09 | 1,097,728 |
| 2022-01-19 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 5,670 | 43.09 | 244,320 |
| 2022-01-10 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 1,000 | .00 | 0 |
| 2022-01-10 | Mehta Kishan | Option Ex | 1,875 | .00 | 0 |
| 2022-01-10 | Stock Elyse (Chief Medical Officer) | Option Ex | 937 | .00 | 0 |
| 2022-01-07 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 1,000 | .00 | 0 |
| 2022-01-07 | Stock Elyse (Chief Medical Officer) | Option Ex | 4,250 | .00 | 0 |
| 2022-01-07 | Coric Vlad (Chief Executive Officer) | Option Ex | 10,000 | .00 | 0 |
| 2022-01-07 | Engelhart James (Strategic Advisor) | Option Ex | 3,250 | .00 | 0 |
| 2022-01-07 | Tilton John (Chief Commercial Officer) | Option Ex | 875 | .00 | 0 |
| 2022-01-07 | Jones William A Jr (CCO-Migraine & Common Disease) | Option Ex | 3,750 | .00 | 0 |
| 2022-01-06 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 875 | .00 | 0 |
| 2022-01-06 | Stock Elyse (Chief Medical Officer) | Option Ex | 5,000 | .00 | 0 |
| 2022-01-06 | Coric Vlad (Chief Executive Officer) | Option Ex | 12,500 | .00 | 0 |
| 2022-01-06 | Conway Charles (Chief Scientific Officer) | Option Ex | 3,750 | .00 | 0 |
| 2022-01-06 | Engelhart James (Strategic Advisor) | Option Ex | 3,750 | .00 | 0 |
| 2022-01-06 | Tilton John (Chief Commercial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2022-01-06 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 3,750 | .00 | 0 |
| 2022-01-06 | Jones William A Jr (CCO-Migraine & Common Disease) | Option Ex | 5,000 | .00 | 0 |
| 2021-12-31 | Buten Matthew (Chief Financial Officer) | Option Ex | 12,500 | .00 | 0 |
| 2021-12-20 | Clark George C. (VP, Chief Accounting Officer) | Sale | 1,915 | 123.84 | 237,153 |
| 2021-12-20 | Gregory Julia P | Sale | 12,000 | 125.00 | 1,500,000 |
| 2021-12-20 | Gregory Julia P | Option Ex | 12,000 | 23.63 | 283,560 |
| 2021-12-15 | Stock Elyse (Chief Medical Officer) | Sale | 21,919 | 105.80 | 2,319,030 |
| 2021-12-15 | Stock Elyse (Chief Medical Officer) | Option Ex | 21,919 | 15.80 | 346,429 |
| 2021-12-14 | Stock Elyse (Chief Medical Officer) | Sale | 6,939 | 105.02 | 728,761 |
| 2021-12-14 | Stock Elyse (Chief Medical Officer) | Option Ex | 6,939 | 15.80 | 109,670 |
| 2021-12-10 | Engelhart James (Chief Financial Officer) | Sale | 35,000 | 102.85 | 3,599,855 |
| 2021-12-10 | Engelhart James (Chief Financial Officer) | Option Ex | 35,000 | .00 | 0 |
| 2021-11-29 | Doogan Declan | Sale | 24,525 | 112.83 | 2,767,082 |
| 2021-11-26 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 5,000 | .00 | 0 |
| 2021-11-25 | Stock Elyse (Chief Medical Officer) | Option Ex | 3,375 | .00 | 0 |
| 2021-11-25 | Coric Vlad (Chief Executive Officer) | Option Ex | 10,950 | .00 | 0 |
| 2021-11-25 | Conway Charles (Chief Scientific Officer) | Option Ex | 3,000 | .00 | 0 |
| 2021-11-25 | Engelhart James (Chief Financial Officer) | Option Ex | 3,700 | .00 | 0 |
| 2021-11-25 | Tilton John (Chief Commercial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2021-11-25 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 3,750 | .00 | 0 |
| 2021-11-25 | Jones William A Jr (CCO-Migraine & Common Disease) | Option Ex | 3,000 | .00 | 0 |
| 2021-11-23 | Clark George C. (VP, Chief Accounting Officer) | Option Ex | 1,915 | 32.42 | 62,084 |
| 2021-11-23 | Conway Charles (Chief Scientific Officer) | Option Ex | 10,885 | 29.16 | 317,461 |
| 2021-11-16 | Doogan Declan | Sale | 37,740 | 116.82 | 4,408,824 |
| 2021-11-16 | Doogan Declan | Option Ex | 559,000 | 23.42 | 13,091,780 |
| 2021-11-15 | Childs John W | Option Ex | 474,200 | 23.42 | 11,105,764 |
| 2021-11-10 | Childs John W | Buy | 5,000 | 123.02 | 615,110 |
| 2021-03-17 | Childs John W | Buy | 13,157 | 76.00 | 999,932 |
| 2021-03-02 | Childs John W | Buy | 10,000 | 85.14 | 851,370 |
| 2021-01-06 | Stock Elyse (Chief Medical Officer) | Option Ex | 5,000 | .00 | 0 |
| 2021-01-06 | Coric Vlad (Chief Executive Officer) | Option Ex | 12,500 | .00 | 0 |
| 2021-01-06 | Conway Charles (Chief Scientific Officer) | Option Ex | 3,750 | .00 | 0 |
| 2021-01-06 | Engelhart James (Chief Financial Officer) | Option Ex | 3,750 | .00 | 0 |
| 2021-01-06 | Tilton John (Chief Commercial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2021-01-06 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 3,750 | .00 | 0 |
| 2021-01-06 | Jones William A Jr (CCO-Migraine & Common Disease) | Option Ex | 5,000 | .00 | 0 |
| 2020-11-25 | Stock Elyse (Chief Medical Officer) | Option Ex | 3,375 | .00 | 0 |
| 2020-11-25 | Coric Vlad (Chief Executive Officer) | Option Ex | 10,950 | .00 | 0 |
| 2020-11-25 | Conway Charles (Chief Scientific Officer) | Option Ex | 3,000 | .00 | 0 |
| 2020-11-25 | Engelhart James (Chief Financial Officer) | Option Ex | 3,700 | .00 | 0 |
| 2020-11-25 | Tilton John (Chief Commercial Officer) | Option Ex | 1,250 | .00 | 0 |
| 2020-11-25 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 3,750 | .00 | 0 |
| 2020-11-25 | Jones William A Jr (CCO-Migraine & Common Disease) | Option Ex | 3,000 | .00 | 0 |
| 2020-11-23 | Childs John W | Buy | 5,000 | 89.55 | 447,735 |
| 2020-11-02 | Jones William A Jr (CCO-Migraine & Common Disease) | Sale | 30,000 | 76.91 | 2,307,210 |
| 2020-11-02 | Jones William A Jr (CCO-Migraine & Common Disease) | Option Ex | 30,000 | 50.72 | 1,521,600 |
| 2020-10-23 | Bailey Gregory | Sale | 10,403 | 79.41 | 826,143 |
| 2020-10-22 | Bailey Gregory | Sale | 24,566 | 79.65 | 1,956,632 |
| 2020-10-19 | Bailey Gregory | Sale | 4,554 | 78.98 | 359,656 |
| 2020-10-16 | Bailey Gregory | Sale | 3,748 | 78.88 | 295,638 |
| 2020-10-12 | Bailey Gregory | Sale | 6,729 | 78.87 | 530,743 |
| 2020-10-08 | Gentile Kimberly (SVP, Clinical Operations) | Sale | 23,500 | 76.49 | 1,797,421 |
| 2020-10-08 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 23,500 | 9.29 | 218,314 |
| 2020-09-21 | Childs John W | Buy | 3,322 | 59.25 | 196,828 |
| 2020-09-11 | Childs John W | Buy | 6,678 | 59.00 | 393,981 |
| 2020-08-11 | Childs John W | Buy | 25,000 | 61.16 | 1,528,925 |
| 2020-07-08 | Berman Robert (Special Projects & Med Ovrsght) | Sale | 58,404 | 75.27 | 4,395,893 |
| 2020-07-08 | Berman Robert (Special Projects & Med Ovrsght) | Option Ex | 58,404 | .61 | 35,626 |
| 2020-07-08 | Bailey Gregory | Sale | 50,000 | 75.52 | 3,776,150 |
| 2020-06-24 | Bailey Gregory | Sale | 3,995 | 69.77 | 278,711 |
| 2020-06-23 | Berman Robert (Special Projects & Med Ovrsght) | Sale | 4,296 | 75.05 | 322,431 |
| 2020-06-23 | Berman Robert (Special Projects & Med Ovrsght) | Option Ex | 4,296 | .61 | 2,620 |
| 2020-06-23 | Bailey Gregory | Sale | 101,643 | 74.05 | 7,526,765 |
| 2020-06-22 | Bailey Gregory | Sale | 80,331 | 72.85 | 5,852,193 |
| 2020-06-19 | Berman Robert (Special Projects & Med Ovrsght) | Sale | 986 | 75.07 | 74,016 |
| 2020-06-19 | Berman Robert (Special Projects & Med Ovrsght) | Option Ex | 986 | .61 | 601 |
| 2020-06-19 | Bailey Gregory | Sale | 164,031 | 71.99 | 11,808,755 |
| 2020-06-18 | Berman Robert (Special Projects & Med Ovrsght) | Sale | 61,314 | 75.65 | 4,638,526 |
| 2020-06-18 | Berman Robert (Special Projects & Med Ovrsght) | Option Ex | 61,314 | 3.10 | 190,379 |
| 2020-06-17 | Gentile Kimberly (SVP, Clinical Operations) | Sale | 24,400 | 70.20 | 1,712,953 |
| 2020-06-17 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 24,400 | 5.60 | 136,640 |
| 2020-06-16 | Doogan Declan | Sale | 60,000 | 68.25 | 4,094,759 |
| 2020-06-15 | Doogan Declan | Sale | 80,000 | 66.82 | 5,345,520 |
| 2020-06-12 | Stock Elyse (Chief Medical Officer) | Sale | 36,966 | 64.44 | 2,382,089 |
| 2020-06-12 | Stock Elyse (Chief Medical Officer) | Option Ex | 36,966 | 26.61 | 983,480 |
| 2020-06-12 | Doogan Declan | Sale | 80,000 | 64.35 | 5,148,080 |
| 2020-06-11 | Engelhart James (Chief Financial Officer) | Sale | 19,772 | 63.60 | 1,257,598 |
| 2020-06-11 | Engelhart James (Chief Financial Officer) | Option Ex | 19,772 | 9.29 | 183,681 |
| 2020-06-11 | Doogan Declan | Sale | 80,000 | 63.28 | 5,062,240 |
| 2020-06-10 | Engelhart James (Chief Financial Officer) | Sale | 53,953 | 67.42 | 3,637,457 |
| 2020-06-10 | Engelhart James (Chief Financial Officer) | Option Ex | 53,953 | 5.17 | 278,775 |
| 2020-06-10 | Tilton John (Chief Commercial Officer) | Sale | 52,000 | 68.05 | 3,538,548 |
| 2020-06-10 | Tilton John (Chief Commercial Officer) | Option Ex | 52,000 | 9.29 | 483,079 |
| 2020-06-08 | Gentile Kimberly (SVP, Clinical Operations) | Sale | 600 | 70.05 | 42,027 |
| 2020-06-08 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 600 | 5.60 | 3,360 |
| 2020-06-05 | Bailey Gregory | Option Ex | 438,200 | 11.02 | 4,827,211 |
| 2020-04-07 | Childs John W | Sale | 200,000 | 32.07 | 6,413,800 |
| 2020-04-06 | Childs John W | Sale | 150,000 | 31.49 | 4,723,950 |
| 2020-01-22 | Aguiar Eric | Sale | 2,021 | 56.96 | 115,120 |
| 2020-01-22 | Aguiar Eric | Option Ex | 2,021 | 34.98 | 70,694 |
| 2020-01-09 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 1,590 | 29.16 | 46,372 |
| 2020-01-09 | Aguiar Eric | Sale | 30,000 | 56.39 | 1,691,700 |
| 2020-01-09 | Aguiar Eric | Option Ex | 30,000 | 9.29 | 278,700 |
| 2020-01-08 | Stock Elyse (Chief Medical Officer) | Option Ex | 937 | 55.91 | 52,387 |
| 2020-01-08 | Aguiar Eric | Option Ex | 1,250 | 55.91 | 69,887 |
| 2019-12-30 | Berman Robert (Special Projects & Med Ovrsght) | Sale | 125,000 | 54.31 | 6,788,750 |
| 2019-12-30 | Berman Robert (Special Projects & Med Ovrsght) | Option Ex | 125,000 | .61 | 76,250 |
| 2019-12-18 | Stock Elyse (Chief Medical Officer) | Option Ex | 3,375 | .00 | 0 |
| 2019-12-18 | Berman Robert (Special Projects & Med Ovrsght) | Option Ex | 625 | .00 | 0 |
| 2019-12-18 | Coric Vlad (Chief Executive Officer) | Option Ex | 10,950 | .00 | 0 |
| 2019-12-18 | Conway Charles (Chief Scientific Officer) | Option Ex | 3,000 | .00 | 0 |
| 2019-12-18 | Engelhart James (Chief Financial Officer) | Option Ex | 3,700 | .00 | 0 |
| 2019-12-18 | Tilton John (CCO-Rare & Neurologic Disorder) | Option Ex | 1,250 | .00 | 0 |
| 2019-12-18 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 3,750 | .00 | 0 |
| 2019-12-18 | Jones William A Jr (CCO-Migraine & Common Disease) | Option Ex | 3,000 | .00 | 0 |
| 2019-12-16 | Aguiar Eric | Sale | 3,537 | 55.13 | 194,984 |
| 2019-12-16 | Aguiar Eric | Option Ex | 3,537 | 20.79 | 73,534 |
| 2019-12-09 | Aguiar Eric | Sale | 4,072 | 55.11 | 224,411 |
| 2019-12-09 | Aguiar Eric | Option Ex | 4,072 | 20.79 | 84,656 |
| 2019-11-22 | Aguiar Eric | Sale | 1,250 | 55.24 | 69,050 |
| 2019-11-22 | Aguiar Eric | Option Ex | 1,250 | 37.54 | 46,925 |
| 2019-11-22 | Gregory Julia P | Sale | 12,000 | 54.75 | 656,952 |
| 2019-11-22 | Gregory Julia P | Option Ex | 12,000 | 23.63 | 283,560 |
| 2019-11-21 | Gentile Kimberly (SVP, Clinical Operations) | Sale | 21,065 | 53.04 | 1,117,203 |
| 2019-11-21 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 21,065 | .61 | 12,849 |
| 2019-11-20 | Gentile Kimberly (SVP, Clinical Operations) | Sale | 3,935 | 53.03 | 208,665 |
| 2019-11-20 | Gentile Kimberly (SVP, Clinical Operations) | Option Ex | 3,935 | .61 | 2,400 |
| 2019-11-20 | Aguiar Eric | Sale | 6,729 | 52.20 | 351,233 |
| 2019-11-20 | Aguiar Eric | Option Ex | 6,729 | 32.42 | 218,154 |
| 2019-10-18 | Stock Elyse (Chief Medical Officer) | Sale | 17,700 | 45.07 | 797,756 |
| 2019-10-18 | Stock Elyse (Chief Medical Officer) | Option Ex | 17,700 | 10.82 | 191,514 |
| 2019-10-15 | Stock Elyse (Chief Medical Officer) | Sale | 800 | 45.01 | 36,008 |
| 2019-10-15 | Stock Elyse (Chief Medical Officer) | Option Ex | 800 | 10.82 | 8,656 |
| 2019-09-11 | Aguiar Eric | Sale | 10,000 | 45.00 | 450,000 |
| 2019-09-11 | Aguiar Eric | Option Ex | 10,000 | 25.51 | 255,100 |
| 2019-08-20 | Bailey Gregory | Buy | 5,000 | 37.65 | 188,250 |
| 2019-06-27 | Berman Robert (Chief Medical Officer) | Buy | 2,500 | 42.30 | 105,750 |
| 2019-06-27 | Engelhart James (Chief Financial Officer) | Buy | 2,500 | 43.05 | 107,625 |
| 2019-06-26 | Coric Vlad (Chief Executive Officer) | Buy | 5,000 | 40.22 | 201,100 |
| 2019-06-26 | Childs John W (Director) | Buy | 10,000 | 40.37 | 403,700 |
| 2019-04-16 | Doogan Declan (Director) | Sale | 50,000 | 61.92 | 3,096,000 |
| 2019-04-12 | Doogan Declan (Director) | Sale | 38,825 | 53.92 | 2,093,444 |
| 2019-03-26 | Doogan Declan (Director) | Sale | 5,824 | 53.72 | 312,865 |
| 2019-03-25 | Bailey Gregory (Director) | Option Ex | 107,500 | 9.29 | 998,674 |
| 2019-03-22 | Doogan Declan (Director) | Sale | 5,351 | 53.66 | 287,134 |
| 2019-03-22 | Childs John W (Director) | Option Ex | 107,500 | 9.29 | 998,674 |
| 2019-03-14 | Coric Vlad (Chief Executive Officer) | Sale | 31,893 | 50.02 | 1,595,447 |
| 2019-03-13 | Coric Vlad (Chief Executive Officer) | Sale | 16,145 | 50.02 | 807,572 |
| 2019-03-12 | Coric Vlad (Chief Executive Officer) | Sale | 51,962 | 50.15 | 2,605,894 |
| 2019-03-12 | Tilton John (Chief Commercial Officer) | Sale | 10,000 | 50.11 | 501,100 |
| 2019-03-12 | Tilton John (Chief Commercial Officer) | Option Ex | 10,000 | 9.29 | 92,899 |
| 2019-03-01 | Doogan Declan (Director) | Sale | 50,595 | 46.30 | 2,342,548 |
| 2019-02-27 | Doogan Declan (Director) | Sale | 50,429 | 45.25 | 2,281,811 |
| 2019-02-26 | Doogan Declan (Director) | Sale | 62,688 | 44.56 | 2,793,375 |
| 2019-02-25 | Doogan Declan (Director) | Sale | 103,131 | 45.49 | 4,691,736 |
| 2019-02-22 | Doogan Declan (Director) | Sale | 64,875 | 44.54 | 2,889,531 |
| 2019-02-21 | Gregory Julia P (Director) | Sale | 12,000 | 43.56 | 522,720 |
| 2019-02-21 | Gregory Julia P (Director) | Option Ex | 12,000 | 23.63 | 283,560 |
| 2019-02-19 | Doogan Declan (Director) | Sale | 1,400 | 45.51 | 63,714 |
| 2019-02-15 | Doogan Declan (Director) | Sale | 678 | 45.42 | 30,794 |
| 2019-02-04 | Aguiar Eric (Director) | Option Ex | 35,218 | 29.61 | 1,042,910 |
| 2019-01-10 | Tilton John (Chief Commercial Officer) | Sale | 10,500 | 37.67 | 395,535 |
| 2019-01-10 | Tilton John (Chief Commercial Officer) | Option Ex | 10,500 | 9.29 | 97,544 |
| 2018-12-03 | Doogan Declan (Director) | Sale | 40,000 | 41.95 | 1,678,000 |
| 2018-06-15 | Gentile Kimberly (VP of Operations) | Sale | 12,500 | 40.02 | 500,250 |
| 2018-06-15 | Gentile Kimberly (VP of Operations) | Option Ex | 12,500 | .61 | 7,625 |
| 2018-06-12 | Berman Robert (Chief Medical Officer) | Sale | 20,257 | 37.53 | 760,346 |
| 2018-06-11 | Berman Robert (Chief Medical Officer) | Sale | 75,492 | 35.89 | 2,709,558 |
| 2018-06-08 | Berman Robert (Chief Medical Officer) | Sale | 8,406 | 36.01 | 302,700 |
| 2018-06-07 | Berman Robert (Chief Medical Officer) | Sale | 2,500 | 36.01 | 90,025 |
| 2018-06-06 | Berman Robert (Chief Medical Officer) | Sale | 16,983 | 36.01 | 611,557 |
| 2018-06-05 | Berman Robert (Chief Medical Officer) | Sale | 6,362 | 36.01 | 229,095 |
| 2018-06-05 | Doogan Declan (Director) | Sale | 49,763 | 35.70 | 1,776,787 |
| 2018-06-04 | Doogan Declan (Director) | Sale | 39,453 | 35.05 | 1,382,827 |
| 2018-06-01 | Coric Vlad (Chief Executive Officer) | Sale | 13,840 | 35.04 | 484,953 |
| 2018-06-01 | Doogan Declan (Director) | Sale | 83,898 | 35.04 | 2,939,785 |
| 2018-05-31 | Coric Vlad (Chief Executive Officer) | Sale | 34,619 | 35.01 | 1,212,011 |
| 2018-05-31 | Doogan Declan (Director) | Sale | 26,044 | 35.01 | 911,800 |
| 2018-05-30 | Coric Vlad (Chief Executive Officer) | Sale | 1,541 | 35.00 | 53,935 |
| 2018-05-30 | Engelhart James (Chief Financial Officer) | Sale | 5,000 | 35.00 | 175,000 |
| 2018-05-30 | Engelhart James (Chief Financial Officer) | Option Ex | 5,000 | .61 | 3,050 |
| 2018-05-30 | Doogan Declan (Director) | Sale | 842 | 35.00 | 29,470 |
| 2018-05-10 | Berman Robert (Chief Medical Officer) | Sale | 35,000 | 27.15 | 950,250 |
| 2018-05-07 | Engelhart James (Chief Financial Officer) | Sale | 2,500 | 27.67 | 69,175 |
| 2018-04-10 | Berman Robert (Chief Medical Officer) | Sale | 35,000 | 25.13 | 879,550 |
| 2018-03-12 | Berman Robert (Chief Medical Officer) | Sale | 35,000 | 30.37 | 1,062,950 |
| 2018-03-01 | Gentile Kimberly (VP of Operations) | Sale | 5,000 | 32.93 | 164,650 |
| 2018-03-01 | Gentile Kimberly (VP of Operations) | Option Ex | 5,000 | .61 | 3,050 |
| 2018-02-21 | Engelhart James (Chief Financial Officer) | Sale | 538 | 29.60 | 15,924 |
| 2018-02-01 | Gentile Kimberly (VP of Operations) | Sale | 5,000 | 33.30 | 166,484 |
| 2018-02-01 | Gentile Kimberly (VP of Operations) | Option Ex | 5,000 | .61 | 3,050 |
| 2018-01-31 | Bailey Gregory (Director) | Sale | 50,000 | 33.46 | 1,672,850 |
| 2018-01-23 | Bailey Gregory (Director) | Sale | 16,000 | 32.79 | 524,640 |
| 2018-01-23 | Portage Biotech Inc. (Other) | Sale | 24,277 | 331,520.00 | 8,048,311,040 |
| 2018-01-22 | Engelhart James (Chief Financial Officer) | Sale | 10,000 | 32.50 | 325,000 |
| 2018-01-22 | Engelhart James (Chief Financial Officer) | Option Ex | 10,000 | .61 | 6,100 |
| 2018-01-22 | Bailey Gregory (Director) | Sale | 9,000 | 32.51 | 292,590 |
| 2018-01-19 | Bailey Gregory (Director) | Sale | 40,000 | 30.15 | 1,206,120 |
| 2018-01-19 | Portage Biotech Inc. (Other) | Sale | 35,119 | 30.04 | 1,054,799 |
| 2018-01-18 | Doogan Declan (Director) | Sale | 27,935 | 28.13 | 785,727 |
| 2018-01-17 | Doogan Declan (Director) | Sale | 61,256 | 26.52 | 1,624,202 |
| 2018-01-16 | Doogan Declan (Director) | Sale | 38,867 | 26.83 | 1,042,801 |
| 2018-01-16 | Bailey Gregory (Director) | Sale | 40,000 | 26.52 | 1,060,800 |
| 2018-01-12 | Doogan Declan (Director) | Sale | 33,442 | 26.36 | 881,531 |
| 2018-01-11 | Doogan Declan (Director) | Sale | 48,138 | 26.52 | 1,276,619 |
| 2018-01-10 | Berman Robert (Chief Medical Officer) | Sale | 35,000 | 28.68 | 1,003,870 |
| 2018-01-10 | Doogan Declan (Director) | Sale | 40,362 | 28.69 | 1,157,985 |
| 2018-01-09 | Portage Biotech Inc. (10% Owner) | Sale | 56,157 | 30.08 | 1,688,977 |
| 2018-01-08 | Portage Biotech Inc. (10% Owner) | Sale | 5,728 | 30.02 | 171,943 |
| 2018-01-05 | Portage Biotech Inc. (10% Owner) | Sale | 22,996 | 30.04 | 690,684 |
| 2018-01-04 | Bailey Gregory (Director) | Sale | 16,976 | 28.77 | 488,399 |
| 2018-01-04 | Portage Biotech Inc. (10% Owner) | Sale | 4,350 | 28.62 | 124,505 |
| 2018-01-03 | Bailey Gregory (Director) | Sale | 33,024 | 28.68 | 947,128 |
| 2018-01-03 | Portage Biotech Inc. (10% Owner) | Sale | 35,650 | 28.61 | 1,020,089 |
| 2018-01-02 | Gentile Kimberly (VP of Operations) | Sale | 5,000 | 27.60 | 138,000 |
| 2018-01-02 | Gentile Kimberly (VP of Operations) | Option Ex | 5,000 | .61 | 3,050 |
| 2017-12-20 | Bailey Gregory (Director) | Sale | 39,430 | 26.41 | 1,041,149 |
| 2017-12-19 | Berman Robert (Chief Medical Officer) | Sale | 10,000 | 24.10 | 241,000 |
| 2017-12-11 | Berman Robert (Chief Medical Officer) | Sale | 25,000 | 21.28 | 532,000 |
| 2017-12-01 | Gentile Kimberly (VP of Operations) | Sale | 5,000 | 22.25 | 111,250 |
| 2017-12-01 | Gentile Kimberly (VP of Operations) | Option Ex | 5,000 | .61 | 3,050 |
| 2017-11-30 | Bailey Gregory (Director) | Sale | 3,030 | 25.47 | 77,174 |
| 2017-11-29 | Bailey Gregory (Director) | Sale | 6,940 | 25.48 | 176,831 |
| 2017-11-27 | Bailey Gregory (Director) | Sale | 20,000 | 25.92 | 518,400 |
| 2017-11-24 | Bailey Gregory (Director) | Sale | 600 | 26.02 | 15,612 |
| 2017-11-14 | Berman Robert (Chief Medical Officer) | Sale | 33,664 | 24.75 | 833,352 |
| 2017-11-13 | Berman Robert (Chief Medical Officer) | Sale | 46,587 | 25.89 | 1,205,904 |
| 2017-11-10 | Berman Robert (Chief Medical Officer) | Sale | 52,326 | 26.31 | 1,376,697 |
| 2017-11-10 | Engelhart James (Chief Financial Officer) | Sale | 8,938 | 26.28 | 234,890 |
| 2017-11-10 | Engelhart James (Chief Financial Officer) | Option Ex | 8,938 | .61 | 5,452 |
| 2017-11-09 | Berman Robert (Chief Medical Officer) | Sale | 27,423 | 26.80 | 734,799 |
| 2017-11-09 | Engelhart James (Chief Financial Officer) | Sale | 21,600 | 26.82 | 579,204 |
| 2017-11-09 | Engelhart James (Chief Financial Officer) | Option Ex | 21,600 | .61 | 13,176 |
| 2017-11-01 | Coric Vlad (Chief Executive Officer) | Sale | 50,000 | 29.36 | 1,468,000 |
| 2017-11-01 | Tilton John (Chief Commercial Officer) | Sale | 30,000 | 29.36 | 880,950 |
| 2017-11-01 | Tilton John (Chief Commercial Officer) | Option Ex | 30,000 | 9.29 | 278,700 |
| 2017-11-01 | Gentile Kimberly (VP of Operations) | Sale | 5,000 | 29.39 | 146,950 |
| 2017-11-01 | Gentile Kimberly (VP of Operations) | Option Ex | 5,000 | .61 | 3,050 |
| 2017-10-31 | Coric Vlad (Chief Executive Officer) | Sale | 100,000 | 29.84 | 2,983,700 |
| 2017-05-09 | Berman Robert (Chief Medical Officer) | Buy | 50 | 17.00 | 850 |
| 2017-05-09 | Conway Charles (Chief Scientific Officer) | Buy | 4,000 | 17.00 | 68,000 |
| 2017-05-09 | Engelhart James (Chief Financial Officer) | Buy | 2,500 | 17.00 | 42,500 |
| 2017-05-09 | Cha Albert (Director) | Buy | 470,000 | 17.00 | 7,990,000 |
| 2017-05-09 | Bailey Gregory (Director) | Buy | 175,000 | 17.00 | 2,975,000 |
| 2017-05-09 | Childs John W (Director) | Buy | 415,000 | 17.00 | 7,055,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BHVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biohaven Pharmaceutical Holding Co Ltd. (symbol BHVN, CIK number 1689813) see the Securities and Exchange Commission (SEC) website.